These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10281367)

  • 1. Editors' roundtable: current formulas for P & T Committee success. (Part 2).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Apr; 22(4):373-82. PubMed ID: 10281367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editors' roundtable: Current formulas for P & T Committee success (Part 1).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Mar; 22(3):288-98. PubMed ID: 10312015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P & T Committee interview: strategies to ensure an effective formulary system.
    Riff L; Hutchinson R
    Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues in formulary management: therapeutic interchange. Communicating a policy: roundtable discussion, Part 2.
    Cichon M; Mahoney C; Renshaw B; Cromer M; Rodriguez FA; DeGiulio H; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():9-12. PubMed ID: 10122037
    [No Abstract]   [Full Text] [Related]  

  • 6. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

  • 9. P & T Committee roundtable discussion: Eastern region. Part I.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jun; 19(6):469-72, 475-6. PubMed ID: 10266565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P & T Committee roundtable discussion: Eastern region Pt. II.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jul; 19(7):561-4, 568-70. PubMed ID: 10267389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P & T Committee roundtable discussion: Great Lakes region. Part II.
    McQuone M; Salberg DJ; Weintraub M
    Hosp Formul; 1984 Feb; 19(2):129-32, 136-8, 147-8. PubMed ID: 10264742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulary decision making in a specialty hospital: effective management of potent and costly drug therapies.
    Keating MJ; Dana WJ
    Hosp Formul; 1990 Jun; 25(6):639-44. PubMed ID: 10113244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
    Mahoney CD
    Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing an effective P & T Committee, Part 2.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P&T Committee and cancer chemotherapy: Part II. Who should prescribe anticancer drugs.
    Krakoff IH
    Hosp Formul; 1982 Apr; 17(4):577-8. PubMed ID: 10254882
    [No Abstract]   [Full Text] [Related]  

  • 18. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 19. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.